| Market Capitalization (Millions $) |
7 |
| Shares
Outstanding (Millions) |
5 |
| Employees |
146 |
| Revenues (TTM) (Millions $) |
1 |
| Net Income (TTM) (Millions $) |
35 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Orgenesis Inc
Orgenesis Inc is a Delaware-based biotechnology company that specializes in the development of advanced cell therapy technologies and regenerative medicines. The company primarily focuses on developing and commercializing autologous cell therapies that can be used for treating a range of diseases, including diabetes, liver disease, and other chronic illnesses.
Orgenesis is headquartered in Germantown, Maryland, with offices and subsidiaries in Israel and Belgium. The company was founded by Dr. Dorit Arad and Dr. Sarah Ferber in 2008, and has since expanded its research and development capabilities to become a leading innovator in the field of cell therapy.
The company's core technology is the Orgenesis Diabetes Cell Therapy (ODCT) platform, which uses a patient's own liver cells to produce insulin in response to glucose levels. This novel approach to diabetes treatment has shown promising results in preclinical studies and clinical trials, offering a potential cure for millions of people living with the disease.
In addition to its work in diabetes, Orgenesis is also developing cell therapies for other chronic diseases and conditions, such as liver disease, pancreatitis, and other autoimmune disorders. The company is also collaborating with leading academic and research institutions, such as the University of California, San Francisco, to advance the field of cell therapy and regenerative medicine.
Orgenesis has a strong intellectual property portfolio, with multiple patents and patent applications for its cell therapy technologies. The company is also committed to responsible and sustainable business practices, with a focus on environmental stewardship, ethical standards, and social responsibility.
Overall, Orgenesis Inc is a leading biotechnology company that is at the forefront of developing innovative, patient-centric solutions for chronic diseases and conditions using advanced cell therapy technologies.
Company Address: 20271 Goldenrod Lane Germantown 20876 MD
Company Phone Number: 659-6404 Stock Exchange / Ticker: ORGS
|
78.39 %